Agarwal Arjun sold ORKA
August 13, 2026 · Form 4 insider transaction
Agarwal Arjun sold 2,132 shares of Oruka Therapeutics, Inc. at $105.57 per share, a transaction worth $225.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,132
Price
$105.57
Total value
$225.1K
InsiderAgarwal Arjun
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 13, 2026
Filing dateAugust 14, 2026
Shares owned after21,080
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.11 to $106.08, inclusive.